Dr. Udayakumar Navaneethan, MD

Dr. Navaneethan practices at Lakeview Surgery Center - HOPD in Orlando, Florida.

Dr. Navaneethan's NPI, 1225227507, was assigned on October 23, 2007. Dr. Navaneethan graduated from Madurai Medical College in 2003. Dr. Navaneethan holds Florida license ME118891.

Dr. Navaneethan's primary practice is Lakeview Surgery Center - HOPD, at 7448 Docs Grove Cir, Orlando, FL 32819.

Dr. Navaneethan's primary practice is Lakeview Surgery Center - HOPD in Orlando, Florida. Dr. Navaneethan is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Navaneethan to 5 more hospitals, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Navaneethan practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Navaneethan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Navaneethan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Navaneethan's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Navaneethan treats.

CMS data shows 609 Medicare services from Dr. Navaneethan across 9 procedure codes in 2024, for 225 Medicare patients. Medicare paid $63,160 for them.

CMS counts 225 Medicare patients who saw Dr. Navaneethan in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Navaneethan's median patient age at 53, with 53% women.

In 2024, Dr. Navaneethan wrote 1,095 Medicare Part D claims for 240 patients. 35% of them were for generic drugs. CMS names the drug for 966 of them, across 24 drugs with 11 or more claims each, at $10,740,887 in total drug cost. In 2023, CMS named 876 claims across 25 drugs.

Dr. Navaneethan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Navaneethan as offering telehealth. CMS counts 321 procedures of colonoscopy by Dr. Navaneethan, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 213 papers to Dr. Navaneethan, published from 2008 to 2025. 2016 was the busiest year, with 14. The most frequent topics are Colitis, Ulcerative, Inflammatory Bowel Diseases and Cholangitis, Sclerosing. Dr. Navaneethan has published most often in Gastrointest Endosc. Dr. Navaneethan's most frequent co-authors are Bo Shen, MD, Shyam S. Varadarajulu, MD and Robert H. Hawes, MD.

Dmand AI links Dr. Navaneethan to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Constriction, Pathologic. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Navaneethan that name 4 trials.

CMS Open Payments shows 1,308 general payments to Dr. Navaneethan from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Janssen Pharmaceuticals, Inc paid the most, $455,693. It also lists 8 research payments totaling $7,375 from 2018 to 2022, naming 4 clinical trials.

Dr. Navaneethan graduated from Madurai Medical College in 2003.

Dr. Navaneethan is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.